Your browser doesn't support javascript.
loading
Solution formulation development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancer.
Liang, Su; Bian, Xiaomei; Liang, Dong; Sivils, Jeffrey C; Neckers, Leonard M; Cox, Marc B; Xie, Huan.
Afiliação
  • Liang S; a Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences , Texas Southern University , Houston , TX , USA .
  • Bian X; a Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences , Texas Southern University , Houston , TX , USA .
  • Liang D; a Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences , Texas Southern University , Houston , TX , USA .
  • Sivils JC; b Department of Biological Sciences, Border Biomedical Research Center , University of Texas at El Paso , El Paso , TX , USA , and.
  • Neckers LM; c Urologic Oncology Branch , National Cancer Institute , Bethesda , MD , USA.
  • Cox MB; b Department of Biological Sciences, Border Biomedical Research Center , University of Texas at El Paso , El Paso , TX , USA , and.
  • Xie H; a Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences , Texas Southern University , Houston , TX , USA .
Pharm Dev Technol ; 21(1): 121-6, 2016.
Article em En | MEDLINE | ID: mdl-25380396

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Química Farmacêutica / Cicloexanos / Modelos Animais de Doenças / Neoplasias de Próstata Resistentes à Castração / Anilidas / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Química Farmacêutica / Cicloexanos / Modelos Animais de Doenças / Neoplasias de Próstata Resistentes à Castração / Anilidas / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article